Skip to content

Chemours CC Equity Method Income

Equity Method Income at other companies

DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
-$1M+93.3%
Cabot Corporation logo
Cabot CorporationCBT
$2M-33.3%
Albemarle logo
AlbemarleALB
$96.29M+49.8%
Dow logo
DowDOW
-$303M-1,415%
Celanese Corporation logo
Celanese CorporationCE
$35M+59.1%
Fluor logo
FluorFLR
$51M+113%

Segments

By segment

See full
Advanced Performance Materials$5M-16.7%
Thermal And Specialized Solutions$3M+50.0%

Other financials

Income statement

See full
Revenue$1.4B+1.0%
Gross profit$212.0M-10.2%
Net income-$29.0M-480%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$563.0M+21.3%
Total debt$4.4B0.0%
Total equity$215.0M-62.0%
Total assets$7.3B-1.5%

Cash flow

See full
Operating cash flow-$44.0M+60.7%
CapEx$49.0M-41.7%
Free cash flow-$93.0M+52.6%

Valuation

See full
Market cap$3B+63.6%

Profitability

See full
Gross margin15.1%-3.8pp
Net margin-7%-7.3pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemours's equity method income?
Chemours (CC) reported equity method income of $8M in Q1 2026.
How has Chemours's equity method income changed year-over-year?
Chemours's equity method income decreased by 0.0% year-over-year, from $8M to $8M.
What is the long-term trend for Chemours's equity method income?
Over 4 years (2021 to 2025), Chemours's equity method income has grown at a -5.7% compound annual growth rate (CAGR), from $43M to $34M.
What does equity method income mean?
The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.